Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 8 studies | 30% ± 8% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
precursor B cell | 3 studies | 20% ± 2% | |
group 3 innate lymphoid cell | 3 studies | 22% ± 2% |
Insufficient scRNA-seq data for expression of ABHD15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 716.01 | 358 / 359 | 100% | 16.50 | 286 / 286 |
pancreas | 100% | 642.67 | 327 / 328 | 100% | 22.54 | 178 / 178 |
thymus | 100% | 905.01 | 653 / 653 | 100% | 17.22 | 602 / 605 |
bladder | 100% | 799.86 | 21 / 21 | 99% | 20.53 | 501 / 504 |
kidney | 100% | 888.76 | 89 / 89 | 99% | 21.86 | 895 / 901 |
lung | 100% | 826.65 | 576 / 578 | 100% | 17.95 | 1151 / 1155 |
breast | 100% | 1531.20 | 459 / 459 | 99% | 20.95 | 1110 / 1118 |
skin | 100% | 581.00 | 1805 / 1809 | 99% | 17.89 | 469 / 472 |
intestine | 100% | 965.33 | 963 / 966 | 99% | 16.90 | 524 / 527 |
esophagus | 100% | 628.92 | 1439 / 1445 | 99% | 17.76 | 182 / 183 |
uterus | 100% | 666.32 | 170 / 170 | 99% | 14.98 | 453 / 459 |
prostate | 100% | 730.32 | 244 / 245 | 98% | 10.38 | 494 / 502 |
ovary | 99% | 420.76 | 178 / 180 | 94% | 7.75 | 406 / 430 |
adrenal gland | 99% | 536.68 | 255 / 258 | 93% | 8.06 | 214 / 230 |
liver | 98% | 1438.25 | 221 / 226 | 93% | 17.68 | 377 / 406 |
brain | 76% | 227.02 | 2007 / 2642 | 98% | 10.00 | 694 / 705 |
adipose | 100% | 2004.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.45 | 29 / 29 |
spleen | 100% | 1353.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.75 | 1 / 1 |
blood vessel | 99% | 626.37 | 1320 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 13.16 | 78 / 80 |
heart | 93% | 453.60 | 803 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 551.39 | 859 / 929 | 0% | 0 | 0 / 0 |
muscle | 71% | 191.07 | 570 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0044255 | Biological process | cellular lipid metabolic process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0060612 | Biological process | adipose tissue development |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0047372 | Molecular function | acylglycerol lipase activity |
GO_0034338 | Molecular function | short-chain carboxylesterase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ABHD15 |
Protein name | Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15) |
Synonyms | UNQ6510/PRO21435 |
Description | FUNCTION: May regulate adipocyte lipolysis and liver lipid accumulation. . |
Accessions | Q6UXT9 ENST00000307201.5 |